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Abstract
Background: Histamine is the prototypical pruritogen used in experimental itch induction. However, in most chronic
pruritic diseases, itch is not predominantly mediated by histamine. Cowhage-induced itch, on the other hand, seems more
characteristic of itch occurring in chronic pruritic diseases.
Objectives: We tested the validity of cowhage as an itch-inducing agent by contrasting it with the classical itch inducer,
histamine, in healthy subjects and atopic dermatitis (AD) patients. We also investigated whether there was a cumulative
effect when both agents were combined.
Methods: Fifteen healthy individuals and fifteen AD patients were recruited. Experimental itch induction was performed in
eczema-free areas on the volar aspects of the forearm, using different itch inducers: histamine, cowhage and their
combination thereof. Itch intensity was assessed continuously for 5.5 minutes after stimulus application using a computer-
assisted visual analogue scale (COVAS).
Results: In both healthy and AD subjects, the mean and peak intensity of itch were higher after the application of cowhage
compared to histamine, and were higher after the combined application of cowhage and histamine, compared to histamine
alone (p,0.0001 in all cases). Itch intensity ratings were not significantly different between healthy and AD subjects for the
same itch inducer used; however AD subjects exhibited a prolonged itch response in comparison to healthy subjects
(p ,0.001).
Conclusions: Cowhage induced a more intense itch sensation compared to histamine. Cowhage was the dominant factor in
itch perception when both pathways were stimulated in the same time. Cowhage-induced itch is a suitable model for the
study of itch in AD and other chronic pruritic diseases, and it can serve as a new model for testing antipruritic drugs in
humans.
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Introduction
Histamine has been the prototypical pruritogen used in
experimental itch induction for many decades [1,2]. However,
in many chronic pruritic conditions, such as atopic dermatitis
(AD), the histaminergic pathway does not seem to play the major
role since antihistamines are known to be largely ineffective. Some
of the characteristics of itch which are common in chronic
pruritus, such as itch occurring without a flare and also the
mechanically-induced itch, cannot be attributed to the histamin-
ergic pathway.
The rationale of this study was to evaluate and establish a new
model of itch in humans, which relates to the PAR-2 pathway.
The PAR-2 receptors have been implicated in the pathophysiology
of itch and of atopic eczema. Cowhage spicules provide an
exogenous route to stimulate PAR-2 receptors in the skin and to
elicit itch. Cutaneous application of spicules of the plant cowhage
(Mucuna pruriens var. pruriens) produces itch without axonal reflex
flare [3–5]. Cowhage-induced itch is also usually accompanied by
a burning and/or pricking sensation [6,7], which appear to
correspond to the nociceptive and burning sensations that
accompany itch in atopic dermatitis [8,9]. Cowhage stimulates
nerve fibers distinct from those activated by histamine, and these
are polymodal C- neurons that can transmit mechanical and other
noxious signals, in addition to itch [10,11]. The active ingredient
of cowhage is mucunain, a cysteine protease, which binds to
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Furthermore, it was previously found that the epidermis and cutaneous
nerve fibers of AD patients express elevated levels of PAR-2 [13].
Other endogenous proteases binding to PAR-2, such as cathepsin S,
mast cell tryptase and kallikrein [14] may play an important role in
mediating pruritus in AD. Therefore, the active ingredient in cowhage,
mucunain, acting as an exogenous PAR-2 ligand, may provide a model
to study itch in AD and other chronic pruritic diseases.
As cowhage has not been employed in previous clinical or
translational studies, we aimed to test the validity of cowhage as an
experimental itch model, and contrast it with histamine, in AD
patients and healthy controls. We also planned to investigate if
there was a summation effect when both agents are administered
simultaneously to induce itch.
Materials and Methods
Subjects and setting
Fifteen healthy individuals and fifteen AD patients were
recruited at the Wake Forest University Health Sciences
Department of Dermatology, Winston-Salem, North Carolina,
USA. This clinical research involving human participants has been
approved by the Internal Review Board of Wake Forest University
Heath Sciences. Informed consent has been obtained in all cases
and the investigation has been conducted according to the
principles expressed in the Declaration of Helsinki. The diagnosis
of AD was made using the Hanifin and Rajka criteria [15]. The
severity of disease was assessed using the Eczema Area and
Severity Index (EASI) [16]. The assessment was performed for all
subjects at a screening visit, prior to experimental itch induction,
by the same investigator (AP). AD subjects had to present a
baseline itch intensity of minimum 3 out of 10 on a Visual Analog
Scale (VAS) in order to qualify, and an eczema-free area on the
volar aspect of either forearm. The AD group included 8 males
and 7 females, average age 32.6611.2 years (age range 21 to 54),
while the healthy group was comprised of 7 males and 8 females,
average age 30.966.0 years (age range 19 to 41).
Subjects were required to cease all systemic antipruritic
medications, including antihistamines, at least 1 week prior to
the study. No topical agents were allowed to be applied to their
forearms for at least 1 week, but these could be used on other parts
of the body.
Itch induction
Itch stimuli were applied alternatively to the volar aspect of the
forearms in the following sequence: histamine (right forearm),
cowhage (left forearm), and cowhage and histamine together (right
forearm). Between itch inductions, a break was taken to allow
previous itch sensations to completely subside. The combination of
the two stimuli was administered on the right forearm in an area
10 cm away from the area where histamine was first applied.
Histamine and cowhage were delivered on eczema-free areas. A
1% solution of histamine dissolved in 2% methylcellulose gel
(Sigma, St. Louis, USA) was delivered using a current of 200 mA
through a round iontophoresis electrode, 14 mm in diameter, for
30 seconds (Perimed PF 3826 Perilont Power device; Perimed,
Sweden) as we previously reported [2]. Itch intensity was assessed
continuously for 5.5 minutes subsequently.
After the itch sensation from histamine iontophoresis had
completely subsided, an eczema-free area on the other forearm
was used for cowhage application. A number of 40 to 45 cowhage
spicules were counted under the microscope, picked-up by a
microtweezer and were applied within a 4 cm
2 circular area on
the skin. The spicules were gently rubbed for 45 seconds onto the
subjects’ skin with a circular motion to facilitate contact; a cotton
cloth was used to demarcate the area to prevent any stray spicules
from stimulating surrounding skin. (A previous study had reported
that 1 spicule was sufficient to induce a significant itch, and
furthermore, there was no difference in sensation intensity when 1
or 7 spicules were inserted over a small area [6]). Subjects were
instructed to ignore the initial stinging or pricking sensations and
rate only the itch sensation per se. After 5.5 minutes, during which
itch intensity was continuously reported, the spicules were
removed using adhesive tapes (3M, St.Paul, MN).
When itch sensation induced by cowhage completely subsided,
an area on the contralateral forearm (10 cm away from the area
that was used for histamine’s single application previously) was
chosen for application of both histamine and cowhage. Histamine
was administered for 30 seconds by iontophoresis as described
above. Immediately thereafter (approximately 1 minute later),
cowhage was applied to an adjacent site (1 cm away). Itch intensity
was assessed continuously for another 5.5 minutes. Subjects were
instructed to rate the itch sensation from both stimuli together
after the application of cowhage was finalized.
Quantitative psychophysical assessment
Subjects used a computerized visual analogue scale (COVAS,
Medoc, Ramat-Yishai, Israel) for continuous reporting of itch
intensity for a duration of 5.5 minutes. The COVAS allows rating
of itch intensity on a 100 mm scale that ranges from ‘‘no itch’’ at
one end to ‘‘unbearable itch’’ at the other. The subjects can slide
an indicator between the two ends to reflect the intensity of their
sensations and the values were continuously registered by a
computer throughout the experimental period. Visual analog
scales have long been used to assess various sensations and have
been shown to exhibit ratio-scale properties for psychophysical
ratings [17] (Price et al. 1994) and to be more reproducible than
verbal descriptor scales [18] (Rosier et al. 2002). Continuous
ratings over time acquired via computerized VAS closely mirror
post-stimulus retrospective ratings [19] (Koyama et al. 2004). We
have adapted the VAS and the COVAS use for ratings of itch
perception and have demonstrated that these scales are 1) sensitive
to manipulations which can reduce itch, 2) capable of assessing
changes in itch intensity over time, and 3) able to distinguish
differences between acute and chronic itch [20,21].
Statistical analysis. COVAS data were sampled at 9 Hz.
Custom written programs in IDL (ITT Visual Information
Solutions, Boulder, CO) were used to extract the peak itch
rating as well as ratings at 30 seconds intervals. These programs
were also used to calculate the average itch over time, and to
calculate group averages.
Using JMP software we examined the entire perception
(intensity ratings) curves for the full duration, identified the peak
value and calculated the means.Peak and mean itch intensity
ratings were analyzed using a two factor analysis of variance
(ANOVA, JMP Software: SAS, Cary, NC) assessing effects of itch
stimulus (cowhage, histamine, and cowhage+histamine) within
subjects, and effects of disease state (healthy vs. atopic patients)
across subjects, as well as the interaction between these factors.
Orthogonal comparisons were used to determine differences
between pairs of itch stimuli.
Time courses of itch were analyzed at 30 seconds intervals using
a three factor analysis of variance (ANOVA), assessing the effects
of time and itch stimulus within subjects, and the effects of disease
status across subjects. As above, orthogonal comparisons were
used to determine differences between pairs of itch stimuli,
compared to the reference value, set for time point=30 seconds.
Cowhage-Induced Itch, an Experimental Model
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17786Separate linear regression analyses were employed for each itch
stimulus in order to determine if the evoked itch intensity was
significantly influenced by the severity of AD, as evaluated by.
EASI scores.
Results
Differences in mean and peak itch intensity ratings for
itch induced by cowhage, histamine and their
combination
Itch intensity measured by COVAS ratings over time in AD
patients and healthy subjects are shown in figures 1 and 2. In both
groups, the mean and peak COVAS ratings were significantly
influenced by the itch stimulus (main effect of stimulus: mean
rating p,0.0001, peak rating: p,0.0001). Both peak and mean
itch ratings were higher following cowhage application versus
following histamine application (both p,0.0001), but were not
significantly different between the combined application of
cowhage and histamine, compared to cowhage alone (contrast of
mean ratings: p=0.89; for peak ratings: p=0.29). Although AD
patients appeared more sensitive to all stimuli, there was no
significant main effect of disease status on itch ratings (mean
rating: p=0.77; peak rating: p=0.36).
Continuous itch response curves reveal a different
pattern of variation over time between AD and healthy
subjects
Analysis of the time course of perceived itch intensity from
continuous ratings revealed that itch intensity varied significantly
across (over) time (analyzed as a main effect time: p,0.0001,
Fig. 1, 2). Ratings gradually rose following the application of the
itch stimuli, and then, after reaching a peak, tapered down slowly
over time. In healthy participants, itch increased faster (following a
steeper slope) and started to subside quicker than in atopic
dermatitis patients. This pattern of time dependency was different
in AD patients vs. healthy subjects (interaction of time6disease
status, p=0.0025). AD patients exhibited a slower onset of itch
than healthy subjects; also, their itch decreased very slowly after it
reached peak values. As in the case of the peak and mean (average
intensity) ratings, a significant main effect of itch stimulus was
detected in the time course data (p,0.0001), and this effect did not
vary with disease status (drug6disease status interaction: p=0.91).
The Relationship between EASI scores and perceived itch
intensity ratings in AD subjects
For histamine-induced itch, the mean COVAS ratings were
positively correlated to the EASI scores (r
2=0.32, p=0.02), and
the peak COVAS ratings also were positively correlated to the
EASI scores (r
2=0.54, p=0.0016). The COVAS ratings for
cowhage-induced itch and for the itch induced by cowhage and
histamine in combination showed no linear relationship with
disease severity as evaluated by EASI scores (Table 1).
Discussion
Histamine is the classic, best known mediator of itch which has
been used as the standard experimental pruritogen in numerous
studies in the past decades. However, a novel, distinct pathway for
itch transmission, which is stimulated by cowhage has been
elucidated in recent years. The spicules of this tropical plant
release upon skin contact a cysteine protease, mucunain, that
binds to PAR2/4 receptors [12] which leads to stimulation of
cutaneous polymodal C-fibers [10]; this pathway is distinct from
the neuronal circuits transmitting histamine itch, and synapses in a
separate subset of spinothalamic secondary neurons [22]. In
chronic pruritic diseases of which AD is the most common, the
histaminergic pathway does not appear to be the most relevant
circuit (antihistamines are ineffective for chronic itch relief).
However, cowhage induces an itch associated with burning and
pricking sensations, commonly observed in AD, and it works via
PAR-2 [12] receptors, which display an increased expression in
atopic skin. These findings support the hypothesis that PAR-2
mediated itch pathway may represent the relevant pathway
predominantly stimulated in AD.
This study showed that the response to cowhage was
reproducible, reliable and consistent in both healthy and AD
Figure 1. Time course of continuous itch intensity ratings (on a visual analog scale of 0 to 100 mm) in atopic dermatitis subjects,
following itch induction with histamine, cowhage and their combination. A significant difference in time course and in the magnitude of
response is observed between cowhage and histamine-induced itch (p,0.0001).
doi:10.1371/journal.pone.0017786.g001
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approximately 45 spicules, equivalent to 45 mg of material
(maximally containing about 90 ng of mucunain) induced a more
intense itch sensation compared to histamine, at a dose of 6 mg
histamine (base) that was contained in the chamber of the drug
delivery electrode. Delivery experiments revealed that the number
of cowhage spicules inserted upon rubbing, as examined under
regular or polarizing light by magnifying lens at 56magnification
(Fig. 3), represents about a third of the total spicules applied,
therefore the actual dose of mucunain deliverable by spicules can
be estimated at 15–30 ng.
The co-stimulation of histaminergic and cowhage-itch pathways
did not results in a summation of itch intensity. The combination
of the stimuli induced an itch that was much more intense than
using histamine alone, but it was not significantly more intense
compared to itch induced by cowhage alone. This suggests that the
major contributor of perceived itch sensation is cowhage, when
both pathways are stimulated concurrently.
We propose that cowhage could be used a suitable model to
induce experimental itch. Cowhage-itch more closely resembles
the characteristics of pruritus in chronic conditions and induces a
more intense sensation compared to histamine. Cowhage-induced
itch appears as the dominant component of itch perception when
these two pathways are stimulated simultaneously. From a
therapeutic standpoint, drugs capable to inhibit cowhage itch
pathway appear promising to pursue for the treatment of chronic
pruritus. Cowhage induce itch could offer a new paradigm to test
antipruritics in humans.
Figure 2. Time course of continuous itch intensity ratings (on a visual analog scale of 0 to 100 mm) in healthy subjects, following
itch induction with histamine, cowhage and their combination. A significant difference in time course and in the magnitude of response is
apparent between cowhage and histamine-induced itch (p,0.0001).
doi:10.1371/journal.pone.0017786.g002
Table 1. EASI scores of the severity of disease in atopic
dermatitis subjects included in the study.
Sbj. # EASI score Age Gender
1 15.0 36 m
2 3.8 25 m
3 12.2 22 f
4 3.8 30 f
5 1.1 24 f
6 0.8 54 f
7 12.9 20 f
8 5.2 40 m
9 3.0 21 f
10 9.3 34 m
11 22.5 41 m
12 2.3 24 f
13 17.3 46 m
14 49.0 49 m
15 16.2 23 m
AVG 11.6 32.6
doi:10.1371/journal.pone.0017786.t001
Figure 3. An image of cowhage spicules inserted into the skin
by gentle rubbing, under polarizing light at 56magnification.
doi:10.1371/journal.pone.0017786.g003
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scores, a validated, objective measure of the severity of atopic
eczema [16], with the subjective perception of itch intensity in AD
subjects. Interestingly, ratings of histamine induced itch were
correlated to the EASI scores, while the perceived intensity of
cowhage induced itch was not. Although we do not have a
definitive explanation for the lack of correlation between EASI
scores and the perception of itch induced with cowhage, we note
note that clinical features such as lichenification, excoriations,
pigmentation and disease extension on body areas (included in this
scoring) may have a limited ability to reflect the subjective
expression of itch severity in patients [23]. Histamine induced itch
causes a neurogenic inflammation, therefore the mechanisms
underlying the inflammatory processes involved in the pathophys-
iological manifestation of atopic dermatitis (factored into the EASI
score) may share a common link with the histamine induced
response, while the itch induced via PAR-2 pathway may not,
since it does not evoke a neurogenic response [10].
Previous studies have shown that AD patients exhibited higher
intensity ratings for histamine induced itch than in healthy
subjects, suggesting that AD subjects present a hypersensitization
of the itch response [20,24]. In this study, we found only a trend
for a higher intensity of itch perception in AD subjects. However,
when analyzing itch intensity fluctuation over time, AD patients
displayed a significantly prolonged itch response compared to
healthy subjects for both stimuli, supporting the notion that AD
involves a neuronal hypersensitization at peripheral and/or
central levels, in similarity with chronic pain [25].
Conclusion
Cowhage induced a much more intense itch sensation
compared to histamine and it was the dominant player in itch
induction when both pathways were activated at the same time.
Cowhage-induced itch could serve as a suitable model for the
study of itch in AD and other chronic itch diseases.
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